12:23 PM EST - AnorMED Inc. : Millennium Pharmaceuticals Inc., a developer of therapeutic products in the areas of cancer and inflammatory diseases, reported an agreement to acquire the Canadian-based biopharmaceutical company AnorMED Inc. in a transaction valued approximately US$515 million. AnorMED, Inc.
T.AOM are trading up $2.93 at $14.03.
